Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.3B | 2.4B | 2.3B | 2.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 932M | 810M | 827M | 828M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 761M | 882M | 909M | 855M |
| Tax provision | 177M | 201M | 188M | 200M |
| Net income | 584M | 681M | 721M | 655M |
| Basic EPS | 3.3 | 3.9 | 4.0 | 3.8 |
| Diluted EPS | 3.3 | 3.9 | 4.0 | 3.7 |
| Basic average shares | 164.2M | 166.0M | 166.7M | 167.0M |
| Diluted average shares | 165.0M | 167.0M | 167.6M | 167.7M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 584M | 681M | 721M | 655M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 1M | 2M | — | 2M |